1,2-dimethylhydrazine decreases expression ISO RGD:10457 6480464 1, 2-Dimethylhydrazine results in decreased expression of CYP4B1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP4B1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:16174780 , PMID:17351261 17alpha-ethynylestradiol affects expression ISO RGD:10457 6480464 Ethinyl Estradiol affects the expression of CYP4B1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:10457 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP4B1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:10457 6480464 Ethinyl Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:16174780 , PMID:17942748 17beta-estradiol multiple interactions ISO RGD:736540 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYP4B1 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of CYP4B1 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:736540 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO RGD:10457 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:14664709 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:26945725 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20566336 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4B1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10457 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10457 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP4B1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP4B1 gene] CTD PMID:17942748 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736540 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2-naphthylamine increases metabolic processing EXP 6480464 CYP4B1 protein results in increased metabolism of 2-Naphthylamine CTD PMID:9310344 2-naphthylamine increases metabolic processing ISO RGD:10457 6480464 CYP4B1 protein results in increased metabolism of 2-Naphthylamine CTD PMID:9310344 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3'-Dichlorobenzidine increases metabolic processing EXP 6480464 CYP4B1 protein results in increased metabolism of 3, 3'-Dichlorobenzidine CTD PMID:9310344 3,3'-Dichlorobenzidine multiple interactions ISO RGD:10457 6480464 lauric acid inhibits the reaction [CYP4B1 protein results in increased metabolism of 3, 3'-Dichlorobenzidine] CTD PMID:9310344 3,3'-Dichlorobenzidine increases metabolic processing ISO RGD:10457 6480464 CYP4B1 protein results in increased metabolism of 3, 3'-Dichlorobenzidine CTD PMID:9310344 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10457 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CYP4B1 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:10457 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of CYP4B1 promoter CTD PMID:26251327 3-chloropropane-1,2-diol multiple interactions ISO RGD:10457 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of CYP4B1 mRNA CTD PMID:33187795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736540 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 3-methylbenzyl alcohol decreases activity EXP 6480464 3-methylbenzyl alcohol results in decreased activity of CYP4B1 protein CTD PMID:12791539 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP4B1 mRNA CTD PMID:23273579 3-methyleneindolenine multiple interactions ISO RGD:736540 6480464 [CYP4B1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine CTD PMID:20187624 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CYP4B1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol affects methylation ISO RGD:10457 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CYP4B1 gene CTD PMID:31683443 4-Ipomeanol affects metabolic processing EXP 6480464 CYP4B1 protein affects the metabolism of 4-ipomeanol CTD PMID:8248926 4-Ipomeanol affects binding EXP 1626415 4-Ipomeanol binds to Cyp4b1 protein RGD 4-Ipomeanol decreases response to substance ISO RGD:10457 6480464 CYP4B1 gene mutant form results in decreased susceptibility to 4-ipomeanol CTD PMID:23748241 4-Ipomeanol increases response to substance EXP 6480464 CYP4B1 protein results in increased susceptibility to 4-ipomeanol CTD PMID:8248926 4-Ipomeanol multiple interactions ISO RGD:10457 6480464 CYP4B1 protein results in increased susceptibility to and results in increased metabolism of and results in increased activity of 4-ipomeanol CTD PMID:23748241 acrolein multiple interactions ISO RGD:736540 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CYP4B1 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO RGD:736540 6480464 Aflatoxin B1 results in decreased expression of CYP4B1 mRNA CTD PMID:32234424 all-trans-retinoic acid increases expression ISO RGD:736540 6480464 Tretinoin results in increased expression of CYP4B1 mRNA CTD PMID:16249480 all-trans-retinoic acid decreases expression ISO RGD:736540 6480464 Tretinoin results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 all-trans-retinol affects activity ISO RGD:10457 6480464 Vitamin A affects the activity of CYP4A11 protein CTD PMID:8602878 alpha-pinene multiple interactions ISO RGD:736540 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CYP4B1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP4B1 mRNA CTD PMID:16483693 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CYP4B1 mRNA CTD PMID:23912714 benzo[a]pyrene decreases expression ISO RGD:736540 6480464 Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA CTD PMID:20106945 benzo[a]pyrene increases expression ISO RGD:10457 6480464 Benzo(a)pyrene results in increased expression of CYP4B1 protein CTD PMID:34472326 benzo[a]pyrene affects methylation ISO RGD:736540 6480464 Benzo(a)pyrene affects the methylation of CYP4B1 3' UTR, Benzo(a)pyrene affects the methylation of CYP4B1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:736540 6480464 Benzo(a)pyrene results in increased methylation of CYP4B1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10457 6480464 Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA CTD PMID:22228805 , PMID:23735875 benzo[b]fluoranthene decreases expression ISO RGD:10457 6480464 benzo(b)fluoranthene results in decreased expression of CYP4B1 mRNA CTD PMID:26377693 Benzo[ghi]perylene increases expression ISO RGD:736540 6480464 1, 12-benzoperylene results in increased expression of CYP4B1 CTD PMID:27234499 Benzo[ghi]perylene multiple interactions ISO RGD:736540 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1, 12-benzoperylene results in increased expression of CYP4B1] CTD PMID:27234499 beta-naphthoflavone decreases expression ISO RGD:736540 6480464 beta-Naphthoflavone results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 , PMID:22258563 bezafibrate affects expression EXP 6480464 Bezafibrate affects the expression of CYP4B1 mRNA CTD PMID:17719200 bifenthrin decreases expression ISO RGD:10457 6480464 bifenthrin results in decreased expression of CYP4B1 mRNA CTD PMID:26071804 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CYP4B1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:10457 6480464 bisphenol A results in increased expression of CYP4B1 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP4A11 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:736540 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CYP4B1 mRNA CTD PMID:24136188 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of CYP4B1 mRNA CTD PMID:22110744 cadmium dichloride decreases expression ISO RGD:10457 6480464 Cadmium Chloride results in decreased expression of CYP4B1 mRNA CTD PMID:11958953 cadmium dichloride increases expression ISO RGD:736540 6480464 Cadmium Chloride results in increased expression of CYP4B1 mRNA CTD PMID:12160620 caffeine increases expression ISO RGD:736540 6480464 Caffeine results in increased expression of CYP4B1 mRNA CTD PMID:18444173 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:17293106 calcitriol decreases expression ISO RGD:736540 6480464 Calcitriol results in decreased expression of CYP4B1 mRNA CTD PMID:27107558 carbon nanotube decreases expression ISO RGD:10457 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 ciguatoxin CTX1B affects expression ISO RGD:10457 6480464 Ciguatoxins affects the expression of CYP4B1 mRNA CTD PMID:18353800 clofibrate increases expression ISO RGD:10457 6480464 Clofibrate results in increased expression of CYP4A11 mRNA CTD PMID:33549593 cobalt atom decreases expression ISO RGD:10457 6480464 Cobalt results in decreased expression of CYP4B1 mRNA CTD PMID:34468815 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CYP4B1 mRNA CTD PMID:24386269 copper atom increases expression EXP 6480464 Copper results in increased expression of CYP4B1 mRNA CTD PMID:22465980 copper(0) increases expression EXP 6480464 Copper results in increased expression of CYP4B1 mRNA CTD PMID:22465980 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CYP4B1 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:736540 6480464 Cyclosporine results in decreased expression of CYP4B1 mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO RGD:736540 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:10457 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 dodecanoic acid multiple interactions ISO RGD:10457 6480464 lauric acid inhibits the reaction [CYP4B1 protein results in increased metabolism of 3, 3'-Dichlorobenzidine] CTD PMID:9310344 elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of CYP4B1 mRNA CTD PMID:11444866 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYP4B1 mRNA CTD PMID:15353170 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP4B1 mRNA CTD PMID:23273579 ethyl methanesulfonate increases expression ISO RGD:736540 6480464 Ethyl Methanesulfonate results in increased expression of CYP4B1 mRNA CTD PMID:23649840 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA CTD PMID:18253720 fenthion increases expression ISO RGD:10457 6480464 Fenthion results in increased expression of CYP4B1 mRNA CTD PMID:34813904 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CYP4B1 mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP4B1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:10457 6480464 Folic Acid results in decreased expression of CYP4B1 mRNA CTD PMID:25629700 genistein decreases expression ISO RGD:736540 6480464 Genistein results in decreased expression of CYP4B1 mRNA CTD PMID:18444173 genistein increases expression ISO RGD:10457 6480464 Genistein results in increased expression of CYP4B1 mRNA CTD PMID:32186404 glycidol multiple interactions ISO RGD:10457 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of CYP4B1 mRNA CTD PMID:33187795 indometacin multiple interactions ISO RGD:736540 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of CYP4B1 mRNA CTD PMID:20097248 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA CTD PMID:18544905 kojic acid multiple interactions ISO RGD:10457 6480464 [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA CTD PMID:17917374 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of CYP4B1 mRNA CTD PMID:24136188 m-tolualdehyde affects activity EXP 6480464 3-methylbenzaldehyde affects the activity of CYP4B1 protein CTD PMID:12791539 m-xylene affects activity EXP 6480464 3-xylene affects the activity of CYP4B1 protein CTD PMID:15204773 m-xylene decreases activity EXP 6480464 3-xylene results in decreased activity of CYP4B1 protein CTD PMID:12791539 , PMID:8598570 mifepristone decreases expression ISO RGD:736540 6480464 Mifepristone results in decreased expression of CYP4B1 mRNA CTD PMID:17584828 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP4B1 mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA more ... CTD PMID:18253720 more ... N-nitrosodiethylamine multiple interactions ISO RGD:10457 6480464 [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA CTD PMID:17917374 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of CYP4B1 mRNA CTD PMID:23947594 O-methyleugenol decreases expression ISO RGD:736540 6480464 methyleugenol results in decreased expression of CYP4B1 mRNA CTD PMID:32234424 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CYP4B1 mRNA CTD PMID:23665939 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP4B1 mRNA CTD PMID:23439660 ozone decreases expression ISO RGD:10457 6480464 Ozone results in decreased expression of CYP4B1 mRNA CTD PMID:16183385 ozone multiple interactions ISO RGD:10457 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYP4B1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP4B1 mRNA CTD PMID:34911549 ozone multiple interactions ISO RGD:736540 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:10457 6480464 Acetaminophen affects the expression of CYP4B1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:736540 6480464 Acetaminophen results in decreased expression of CYP4B1 mRNA CTD PMID:29067470 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of CYP4B1 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP4B1 mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10457 6480464 perfluorooctane sulfonic acid affects the expression of CYP4A11 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP4B1 mRNA CTD PMID:16221955 , PMID:28511854 perfluorooctanoic acid affects expression ISO RGD:10457 6480464 perfluorooctanoic acid affects the expression of CYP4A11 mRNA CTD PMID:19429403 perfluorooctanoic acid increases activity ISO RGD:10457 6480464 perfluorooctanoic acid results in increased activity of CYP4A11 protein CTD PMID:8602878 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP4B1 mRNA CTD PMID:12082028 , PMID:23273579 phenobarbital affects expression ISO RGD:10457 6480464 Phenobarbital affects the expression of CYP4B1 mRNA CTD PMID:23091169 phlorizin increases expression ISO RGD:10457 6480464 Phlorhizin results in increased expression of CYP4A11 mRNA CTD PMID:22538082 pirinixic acid decreases expression ISO RGD:10457 6480464 pirinixic acid results in decreased expression of CYP4B1 mRNA CTD PMID:18467677 pirinixic acid increases expression ISO RGD:10457 6480464 pirinixic acid results in increased expression of CYP4B1 mRNA CTD PMID:17426115 , PMID:23811191 pirinixic acid multiple interactions ISO RGD:10457 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP4B1 mRNA] CTD PMID:18467677 potassium dichromate increases expression ISO RGD:10457 6480464 Potassium Dichromate results in increased expression of CYP4B1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP4B1 mRNA CTD PMID:15596064 progesterone multiple interactions ISO RGD:736540 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CYP4B1 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:736540 6480464 Progesterone results in increased expression of CYP4B1 mRNA CTD PMID:17404688 resveratrol multiple interactions ISO RGD:736540 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP4B1 mRNA CTD PMID:23557933 ritonavir affects expression EXP 6480464 Ritonavir affects the expression of CYP4B1 mRNA CTD PMID:17719200 ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of CYP4B1 mRNA CTD PMID:17719200 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP4B1 mRNA CTD PMID:28374803 selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of CYP4B1 mRNA CTD PMID:11444866 silicon dioxide decreases expression ISO RGD:736540 6480464 Silicon Dioxide results in decreased expression of CYP4B1 mRNA CTD PMID:22300531 simazine increases expression EXP 6480464 Simazine results in increased expression of CYP4A11 protein CTD PMID:9711812 skatole multiple interactions ISO RGD:736540 6480464 [CYP4B1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine CTD PMID:20187624 skatole increases metabolic processing ISO RGD:736540 6480464 CYP4B1 protein results in increased metabolism of Skatole CTD PMID:20187624 sodium arsenite decreases expression ISO RGD:10457 6480464 sodium arsenite results in decreased expression of CYP4A11 mRNA CTD PMID:31532247 sodium arsenite decreases expression ISO RGD:736540 6480464 sodium arsenite results in decreased expression of CYP4B1 mRNA CTD PMID:29301061 sodium arsenite affects methylation ISO RGD:736540 6480464 sodium arsenite affects the methylation of CYP4B1 gene CTD PMID:28589171 succimer multiple interactions ISO RGD:10457 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4B1 mRNA CTD PMID:26378955 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP4B1 mRNA CTD PMID:20371263 tamoxifen affects expression ISO RGD:10457 6480464 Tamoxifen affects the expression of CYP4B1 mRNA CTD PMID:17555576 terephthalic acid increases expression EXP 6480464 terephthalic acid results in increased expression of CYP4B1 mRNA CTD PMID:16673812 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP4B1 mRNA CTD PMID:21515302 testosterone increases expression EXP 6480464 Testosterone results in increased expression of CYP4B1 mRNA CTD PMID:11311483 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CYP4B1 mRNA CTD PMID:26496021 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP4B1 mRNA CTD PMID:16239168 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP4B1 mRNA CTD PMID:30012374 titanium dioxide multiple interactions ISO RGD:10457 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 toluene affects expression EXP 6480464 Toluene affects the expression of CYP4B1 mRNA CTD PMID:18653662 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP4B1 mRNA CTD PMID:33387578 triclosan increases expression ISO RGD:736540 6480464 Triclosan results in increased expression of CYP4B1 mRNA CTD PMID:29849464 trimellitic anhydride decreases expression ISO RGD:10457 6480464 trimellitic anhydride results in decreased expression of CYP4B1 mRNA CTD PMID:19042947 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP4B1 mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:736540 6480464 Valproic Acid results in decreased methylation of CYP4B1 gene CTD PMID:29501571 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP4B1 mRNA CTD PMID:35594946 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CYP4B1 mRNA CTD PMID:19015723 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:12672911 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of CYP4B1 mRNA, Zinc results in increased expression of CYP4B1 mRNA CTD PMID:11717422 , PMID:17074742 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of CYP4B1 mRNA CTD PMID:17074742 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of CYP4B1 mRNA, Zinc results in increased expression of CYP4B1 mRNA CTD PMID:11717422 , PMID:17074742 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:12672911 zoledronic acid increases expression ISO RGD:736540 6480464 zoledronic acid results in increased expression of CYP4B1 mRNA CTD PMID:24714768
